ECG market keeps evolving thanks to AI, home monitoring and Epic integration
Dave Fornell | February 10, 2026 | Cardiovascular Business | Electrocardiography
Image courtesy of HeartBeam.
The world of cardiovascular diagnostics has evolved quickly in recent years, making the leap from traditional electrocardiogram (ECG) systems and event recorders to systems integrated with artificial intelligence (AI) and near real-time at home monitoring systems.
Signify Research has published a new report about the biggest developments in these critical trends.
“After a breakthrough year in 2025, which saw the expansion of reimbursement for AI-ECG analysis and the launch of the first commercial AI-ECG platform by Philips, the AI in ECG market should continue to evolve in 2026,” Signify Senior Market Analyst Gareth Jones explained in the report.
For years, the ECG system market appeared relatively static, but that is quickly changing.
AI-ECG vendor AccurKardia recently gained U.S. Food and Drug Administration (FDA) clearance for AccurECG 2.0, an enterprise-grade, device-agnostic AI-ECG interpretation platform. Jones noted that the company is already partnering with remote cardiac monitoring vendors WellySis and Octagos Health. It has a growing pipeline of proprietary AI ECG algorithms, including an FDA breakthrough device designation for algorithms to detect aortic valve stenosis (AS) and hyperkalemia.
HeartSciences submitted its MyoVista wavECG portable 12-lead resting ECG device to the FDA for review. The device was designed from the ground up to incorporate AI-ECG algorithms developed by HeartSciences and third party vendors. HeartSciences also developed a cloud-native ECG management system that can integrate with proprietary and third-party AI ECG algorithms.
In addition, Jones added, Philips and Fukuda Denshi both recently released new resting ECG systems.
Read more from Signify Research here.
AliveCor entered this market in 2024 with its AI-based Kardia 12L system, which uses AI to derive a 12-lead ECG and is currently targeting rural and resource-poor primary and secondary care practices. In January, AliveCor announced receiving FDA clearance for five new AI cardiac findings with its for Kardia 12L. The system now offers a total of 39 algorithms to help clinicians quickly identify various cardiac presentations.
Jones said other companies are also expected to join the AI-ECG interpretation market, including Netherlands-based Cordys Analytics and Ireland-based PulseAI. Cordys has partnered with large Dutch telehealth vendor Ksyos to offer ECG analysis services based on its Galvo 12L ECG analysis platform. PulseAI recently announced a funding round in January for the development of its AI-ECG platform and support its planned FDA 510(k) submission.
Integrating report ECG monitoring into Epic
Epic is the largest U.S. electronic medical record (EMR) provider. For that reason, vendors in the ECG space push to make it as easy as possible for users to integrate them directly into Epic. It is both a selling point and a major convenience factor for health systems that want to streamline integrations to make this convenient from an IT perspective.
iRhythm integrated into Epic in 2024, for example, followed by Philips and Boston Scientific one year later.
Remote ECG monitoring expands
Traditional Holter monitoring systems and event monitors required wired leads and only recorded data that had to be downloaded after the devices were turned. These are rapidly being replaced by small, simple, patch-like monitors that provide real-time monitoring with AI.
HeartBeam has already received FDA clearance for its 12-lead ECG AI synthesis software and a credit-card-sized personal ECG device. Jones said other U.S. vendors are expected to enter the market in 2026, including Wearlinq and Peerbridge Health. Peerbridge has already submitted its next-generation ECG patch, Cor MDx, to the FDA.
New markets
After South Korean vendor Huinno gained FDA approval for its Memo Patch M, Jones said other South Korean vendors are now in the market, including Samsung spin-off WellySis, Me-Zoo and ATsens. WellySis has already partnered with Octagos Health and AccurKardia.
Jones said AI-based remote ECG monitoring systems are also seeing rapid expansion outside the U.S. in resource poor regions in Eastern Europe, India, Latin America, the Middle East and Asia.
Japanese tech giant Omron is also interested in entering the market with the launch a home blood pressure monitor with AI-based atrial fibrillation detection. Omron has partnered and invested in Indian AI-ECG vendor Tricog Health in addition to acquiring the Heartnote Holter Monitoring business from Japan-based JSR Corp. for future expansion efforts.